Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Depression

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 99 articles:
HTML format



Single Articles


    May 2021
  1. TOROUS J
    Digital Interventions for Adults With Symptoms of Depression and Children and Adolescents With Symptoms of Obsessive-Compulsive Disorder.
    JAMA. 2021;325:1839-1840.
    PubMed    


  2. ASPVALL K, Andersson E, Melin K, Norlin L, et al
    Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial.
    JAMA. 2021;325:1863-1873.
    PubMed     Abstract available


  3. ARAYA R, Menezes PR, Claro HG, Brandt LR, et al
    Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials.
    JAMA. 2021;325:1852-1862.
    PubMed     Abstract available


    April 2021
  4. EL-BATTRAWY I, Behnes M, Akin I
    Depression and Incident Cardiovascular Disease.
    JAMA. 2021;325:1679-1680.
    PubMed    


  5. DAVIDSON KW, Pennells L, Di Angelantonio E
    Depression and Incident Cardiovascular Disease-Reply.
    JAMA. 2021;325:1680.
    PubMed    


  6. SLOMSKI A
    Low-Income African American Women With Hypertension and Depression.
    JAMA. 2021;325:1602.
    PubMed    


    March 2021
  7. BAGLEY SM
    I Am Not Burned Out.
    JAMA. 2021;325:1155-1156.
    PubMed    


  8. MORIN L, Savale L, Pham T, Colle R, et al
    Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
    JAMA. 2021 Mar 17. pii: 2777787. doi: 10.1001/jama.2021.3331.
    PubMed     Abstract available


    December 2020
  9. RUBIN R
    Postpartum Depression Persists Longer Than Previously Thought.
    JAMA. 2020;324:2475.
    PubMed    


  10. HARSHFIELD EL, Pennells L, Schwartz JE, Willeit P, et al
    Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
    JAMA. 2020;324:2396-2405.
    PubMed     Abstract available


    October 2020
  11. BAUM A, Wisnivesky J, Basu S, Siu AL, et al
    Association of Geographic Differences in Prevalence of Uncontrolled Chronic Conditions With Changes in Individuals' Likelihood of Uncontrolled Chronic Conditions.
    JAMA. 2020;324:1429-1438.
    PubMed     Abstract available


    August 2020
  12. SLOMSKI A
    Aspirin Fails to Prevent Depression in Older Adults.
    JAMA. 2020;324:733.
    PubMed    


  13. ALI MK, Chwastiak L, Poongothai S, Emmert-Fees KMF, et al
    Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    JAMA. 2020;324:651-662.
    PubMed     Abstract available


  14. OKEREKE OI, Reynolds CF 3rd, Mischoulon D, Chang G, et al
    Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    JAMA. 2020;324:471-480.
    PubMed     Abstract available


    July 2020
  15. JABBAR A, Ingoe L, Junejo S, Carey P, et al
    Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial.
    JAMA. 2020;324:249-258.
    PubMed     Abstract available


  16. VANDERWEELE TJ
    Challenges Estimating Total Lives Lost in COVID-19 Decisions: Consideration of Mortality Related to Unemployment, Social Isolation, and Depression.
    JAMA. 2020 Jul 8. pii: 2768250. doi: 10.1001/jama.2020.12187.
    PubMed    


    June 2020
  17. KUEHN BM
    Postpartum Depression Screening Needs More Consistency.
    JAMA. 2020;323:2454.
    PubMed    


  18. LEVIS B, Sun Y, He C, Wu Y, et al
    Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis.
    JAMA. 2020;323:2290-2300.
    PubMed     Abstract available



  19. Drugs for Depression.
    JAMA. 2020;323:2188-2189.
    PubMed    


    March 2020
  20. RUBIN R
    Matters of the Mind-Sleep Medications and Dementia Risk, Depression and Weight Gain, Opioids and Mental Disorders.
    JAMA. 2020 Mar 25. pii: 2763816. doi: 10.1001/jama.2020.1836.
    PubMed    


  21. SLOMSKI A
    Online Mindfulness Therapy Improves Residual Depression.
    JAMA. 2020;323:1124.
    PubMed    


    December 2019
  22. FLINT AJ, Banerjee S, Marino P
    Continuing Antipsychotic Medication for Patients With Psychotic Depression in Remission-Reply.
    JAMA. 2019;322:2443-2444.
    PubMed    


  23. MUNKHOLM K, Jorgensen KJ, Paludan-Muller AS
    Continuing Antipsychotic Medication for Patients With Psychotic Depression in Remission.
    JAMA. 2019;322:2443.
    PubMed    


    October 2019
  24. SLOMSKI A
    Esketamine Prevents Treatment-Resistant Depression Relapse.
    JAMA. 2019;322:1544.
    PubMed    


  25. ZIMMERMAN M
    Using the 9-Item Patient Health Questionnaire to Screen for and Monitor Depression.
    JAMA. 2019 Oct 18. pii: 2753532. doi: 10.1001/jama.2019.15883.
    PubMed    


  26. BRENT DA, Porta G
    Error in Coding of Questionnaire Scale in Study of Depression in Adolescents.
    JAMA. 2019 Oct 14. pii: 2753207. doi: 10.1001/jama.2019.12855.
    PubMed    


    August 2019
  27. FLINT AJ, Meyers BS, Rothschild AJ, Whyte EM, et al
    Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.
    JAMA. 2019;322:622-631.
    PubMed     Abstract available


  28. CORYELL WH
    Maintenance Treatment for Psychotic Depressive Disorders: Progress and Remaining Challenges.
    JAMA. 2019;322:615-617.
    PubMed    


    July 2019
  29. SLOMSKI A
    Yoga for Anxiety and Depression Associated With Parkinson Disease.
    JAMA. 2019;322:296.
    PubMed    


  30. SLOMSKI A
    Esketamine Nasal Spray Effective in Treatment-Resistant Depression.
    JAMA. 2019;322:296.
    PubMed    


  31. MA J, Venditti EM, Snowden MB
    Collaborative Care for Adults With Obesity and Depression-Reply.
    JAMA. 2019;322:368.
    PubMed    


  32. BROUWER IA, Penninx BWHJ, Visser M
    Multinutrient Supplementation for Prevention of Major Depressive Disorder in Overweight Adults-Reply.
    JAMA. 2019;322:366-367.
    PubMed    


  33. MOULTON CD, Tharmaraja T, Hopkins CWP
    Collaborative Care for Adults With Obesity and Depression.
    JAMA. 2019;322:367-368.
    PubMed    


  34. RUCKLIDGE JJ, Richardson AJ
    Multinutrient Supplementation for Prevention of Major Depressive Disorder in Overweight Adults.
    JAMA. 2019;322:366.
    PubMed    


  35. ROSA RG, Falavigna M, da Silva DB, Sganzerla D, et al
    Effect of Flexible Family Visitation on Delirium Among Patients in the Intensive Care Unit: The ICU Visits Randomized Clinical Trial.
    JAMA. 2019;322:216-228.
    PubMed     Abstract available



  36. Brexanolone (Zulresso) for Postpartum Depression.
    JAMA. 2019;322:73-74.
    PubMed    


    June 2019
  37. SLOMSKI A
    Cariprazine Benefits Patients With Bipolar Depression.
    JAMA. 2019;321:2396.
    PubMed    


    May 2019
  38. KOHLER-FORSBERG O, Cusin C, Nierenberg AA
    Evolving Issues in the Treatment of Depression.
    JAMA. 2019 May 24. pii: 2735004. doi: 10.1001/jama.2019.4990.
    PubMed    


  39. FARRELL CM
    Systole and Diastole, Strength and Openness.
    JAMA. 2019;321:1871-1872.
    PubMed    


    April 2019
  40. CUIJPERS P
    Additional Approaches to Treatment of Depression-Reply.
    JAMA. 2019;321:1635-1636.
    PubMed    


  41. KAZANTZIS N, Hofmann SG
    Additional Approaches to Treatment of Depression.
    JAMA. 2019;321:1635.
    PubMed    


  42. CARNEY RM
    Additional Approaches to Treatment of Depression.
    JAMA. 2019;321:1634-1635.
    PubMed    


  43. SANCAR F
    New Therapy for Treatment-Resistant Depression.
    JAMA. 2019;321:1449.
    PubMed    


    March 2019
  44. MA J, Rosas LG, Lv N, Xiao L, et al
    Effect of Integrated Behavioral Weight Loss Treatment and Problem-Solving Therapy on Body Mass Index and Depressive Symptoms Among Patients With Obesity and Depression: The RAINBOW Randomized Clinical Trial.
    JAMA. 2019;321:869-879.
    PubMed     Abstract available


  45. BERK M, Jacka FN
    Diet and Depression-From Confirmation to Implementation.
    JAMA. 2019;321:842-843.
    PubMed    


  46. BOT M, Brouwer IA, Roca M, Kohls E, et al
    Effect of Multinutrient Supplementation and Food-Related Behavioral Activation Therapy on Prevention of Major Depressive Disorder Among Overweight or Obese Adults With Subsyndromal Depressive Symptoms: The MooDFOOD Randomized Clinical Trial.
    JAMA. 2019;321:858-868.
    PubMed     Abstract available


    February 2019
  47. DIAMOND R
    Promoting Sensible Parenting Policies: Leading by Example.
    JAMA. 2019;321:645-646.
    PubMed    


  48. LEE H, Herbert RD, McAuley JH
    Mediation Analysis.
    JAMA. 2019;321:697-698.
    PubMed    


  49. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Interventions to Prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2019;321:580-587.
    PubMed     Abstract available


  50. O'CONNOR E, Senger CA, Henninger ML, Coppola E, et al
    Interventions to Prevent Perinatal Depression: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2019;321:588-601.
    PubMed     Abstract available


  51. JIN J
    Counseling Interventions to Prevent Perinatal Depression.
    JAMA. 2019;321:620.
    PubMed    


  52. FREEMAN MP
    Perinatal Depression: Recommendations for Prevention and the Challenges of Implementation.
    JAMA. 2019;321:550-552.
    PubMed    


  53. ABBASI J
    New Deep Brain Stimulation Target for Mood Disorders.
    JAMA. 2019;321:537.
    PubMed    


  54. HAMPTON T
    Pattern of Brain Activity Linked to Low Mood in People With High Trait Anxiety.
    JAMA. 2019;321:442-443.
    PubMed    


    November 2018
  55. CUIJPERS P
    The Challenges of Improving Treatments for Depression.
    JAMA. 2018 Nov 30. pii: 2717734. doi: 10.1001/jama.2018.17824.
    PubMed    


  56. KIM JM, Stewart R, Yoon JS
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome-Reply.
    JAMA. 2018;320:2152-2153.
    PubMed    


  57. RUST G
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome.
    JAMA. 2018;320:2152.
    PubMed    


  58. ZIMMERMANN FM, El Farissi M, Tonino PAL
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome.
    JAMA. 2018;320:2151-2152.
    PubMed    


  59. THOMBS BD, Ziegelstein RC
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome.
    JAMA. 2018;320:2151.
    PubMed    


  60. QATO DM, Olfson M
    Medications With Depression as an Adverse Effect-Reply.
    JAMA. 2018;320:1816.
    PubMed    


  61. AGUSTINI B, Berk M
    Medications With Depression as an Adverse Effect.
    JAMA. 2018;320:1815.
    PubMed    


  62. BURCH PBM
    Medications With Depression as an Adverse Effect.
    JAMA. 2018;320:1815-1816.
    PubMed    


    October 2018
  63. SLOMSKI A
    Repetitive TMS for Treating Depression in Veterans.
    JAMA. 2018;320:1631.
    PubMed    


    August 2018
  64. RUBIN R
    Exploring the Relationship Between Depression and Dementia.
    JAMA. 2018 Aug 22. pii: 2698084. doi: 10.1001/jama.2018.11154.
    PubMed    


    July 2018
  65. KIM JM, Stewart R, Lee YS, Lee HJ, et al
    Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial.
    JAMA. 2018;320:350-358.
    PubMed     Abstract available


  66. SLOMSKI A
    Brain Marker Predicts Depression Outcomes.
    JAMA. 2018;320:332.
    PubMed    


  67. HAMPTON T
    New Genetic Links to Depression May Pave the Way for Novel Treatment Strategies.
    JAMA. 2018;320:20-21.
    PubMed    


    June 2018
  68. QATO DM, Ozenberger K, Olfson M
    Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States.
    JAMA. 2018;319:2289-2298.
    PubMed     Abstract available


    May 2018
  69. RUBIN R
    Factors Linked to Depression in Sexual Minority Youth.
    JAMA. 2018;319:2068.
    PubMed    


    February 2018
  70. GUPTA R
    I Solemnly Share.
    JAMA. 2018;319:549-550.
    PubMed    


    January 2018
  71. JAKOBSEN GS, Smastuen MC, Sandbu R, Nordstrand N, et al
    Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities.
    JAMA. 2018;319:291-301.
    PubMed     Abstract available


    November 2017
  72. HEDAYATI SS, Gregg LP, Carmody T, Jain N, et al
    Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
    JAMA. 2017;318:1876-1890.
    PubMed     Abstract available


  73. ABBASI J
    Ketamine Minus the Trip: New Hope for Treatment-Resistant Depression.
    JAMA. 2017 Nov 8. doi: 10.1001/jama.2017.12975.
    PubMed    


  74. WALTHER CP, Shah AA, Winkelmayer WC
    Treating Depression in Patients With Advanced CKD: Beyond the Generalizability Frontier.
    JAMA. 2017 Nov 3. doi: 10.1001/jama.2017.17553.
    PubMed    


    October 2017
  75. KOK RM, Reynolds CF 3rd
    Nonpharmacologic Treatments for Depression in Older Adults-Reply.
    JAMA. 2017;318:1284.
    PubMed    


  76. GITLIN LN, Aravena JM
    Nonpharmacologic Treatments for Depression in Older Adults.
    JAMA. 2017;318:1283-1284.
    PubMed    


    August 2017
  77. HIRSCHTRITT ME, Kroenke K
    Screening for Depression.
    JAMA. 2017;318:745-746.
    PubMed    


    July 2017
  78. FAVA M
    Lessons Learned From the VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D) Study.
    JAMA. 2017;318:126-128.
    PubMed    


  79. MOHAMED S, Johnson GR, Chen P, Hicks PB, et al
    Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.
    JAMA. 2017;318:132-145.
    PubMed     Abstract available


    May 2017
  80. KOK RM, Reynolds CF 3rd
    Management of Depression in Older Adults: A Review.
    JAMA. 2017;317:2114-2122.
    PubMed     Abstract available


    April 2017
  81. FRIEDRICH MJ
    Depression Is the Leading Cause of Disability Around the World.
    JAMA. 2017;317:1517.
    PubMed    


  82. OBERLANDER TF, Zwaigenbaum L
    Disentangling Maternal Depression and Antidepressant Use During Pregnancy as Risks for Autism in Children.
    JAMA. 2017;317:1533-1534.
    PubMed    


  83. RAHMAN A, van Ommeren M, Farooq S
    Interventions for Anxiety and Depression in Conflict-Affected Areas-Reply.
    JAMA. 2017;317:1376-1377.
    PubMed    


  84. LEE KY, Lam MH, Deng Y
    Interventions for Anxiety and Depression in Conflict-Affected Areas.
    JAMA. 2017;317:1376.
    PubMed    


    March 2017

  85. Decline in Postpartum Depression.
    JAMA. 2017;317:1207.
    PubMed    


  86. GEORGE DR, de Boer C, Green MJ
    "That Landscape Is Where I'd Like to Be ... ": Offering Patients With Cancer a Choice of Artwork.
    JAMA. 2017;317:890-892.
    PubMed    


    February 2017
  87. GILBODY S, Lewis H, Adamson J, Atherton K, et al
    Effect of Collaborative Care vs Usual Care on Depressive Symptoms in Older Adults With Subthreshold Depression: The CASPER Randomized Clinical Trial.
    JAMA. 2017;317:728-737.
    PubMed     Abstract available


  88. KROENKE K
    When and How to Treat Subthreshold Depression.
    JAMA. 2017;317:702-704.
    PubMed    


  89. ABBASI J
    Unveiling the "Magic" of Diabetes Remission After Weight-Loss Surgery.
    JAMA. 2017;317:571-574.
    PubMed    


  90. SEDERER LI
    The One With Friends: A TV Show Within a Play.
    JAMA. 2017;317:568-569.
    PubMed    


    January 2017
  91. ABBASI J
    23andMe, Big Data, and the Genetics of Depression.
    JAMA. 2017;317:14-16.
    PubMed    


    December 2016
  92. CHIBANDA D, Weiss HA, Verhey R, Simms V, et al
    Effect of a Primary Care-Based Psychological Intervention on Symptoms of Common Mental Disorders in Zimbabwe: A Randomized Clinical Trial.
    JAMA. 2016;316:2618-2626.
    PubMed     Abstract available


  93. RAHMAN A, Hamdani SU, Awan NR, Bryant RA, et al
    Effect of a Multicomponent Behavioral Intervention in Adults Impaired by Psychological Distress in a Conflict-Affected Area of Pakistan: A Randomized Clinical Trial.
    JAMA. 2016;316:2609-2617.
    PubMed     Abstract available


  94. ROTENSTEIN LS, Ramos MA, Torre M, Segal JB, et al
    Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students: A Systematic Review and Meta-Analysis.
    JAMA. 2016;316:2214-2236.
    PubMed     Abstract available


    November 2016
  95. EL-JAWAHRI A, LeBlanc T, VanDusen H, Traeger L, et al
    Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    JAMA. 2016;316:2094-2103.
    PubMed     Abstract available


    October 2016
  96. GINSBURG S, Levinson W
    Professional Boundaries.
    JAMA. 2016;316:1706-1707.
    PubMed    


  97. ANGERMANN CE, Deckert J, Ertl G
    Escitalopram and Outcomes Among Patients With Depression and Heart Failure-Reply.
    JAMA. 2016;316:1494-1495.
    PubMed    


  98. STROHLE A, Rieckmann N
    Escitalopram and Outcomes Among Patients With Depression and Heart Failure.
    JAMA. 2016;316:1494.
    PubMed    


    September 2016
  99. SLOMSKI A
    Simple, Less Expensive Psychotherapy Effective for Depression.
    JAMA. 2016;316:1250.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Depression is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: